Ragosa Mark bought KNSA
September 1, 2026 · Form 4 insider transaction
Ragosa Mark bought 1,591 shares of Kiniksa Pharmaceuticals International, plc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,591
Price
N/A
Total value
N/A
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after22,189
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.